# Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

> **NCT00005616** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 12 (estimated)

## Conditions studied

- Colorectal Cancer
- Metastatic Cancer

## Interventions

- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** radionuclide imaging
- **RADIATION:** iodine I 131 monoclonal antibody F19

## Key facts

- **NCT ID:** NCT00005616
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** 2000-08
- **Final completion:** 2000-08
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2013-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005616, "Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*